Fuller H B CO FUL
We take great care to ensure that the data presented and summarized in this overview for FULLER H B CO is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding FUL
View all-
Black Rock Inc. New York, NY8.35MShares$486 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.41MShares$373 Million0.01% of portfolio
-
State Street Corp Boston, MA2.83MShares$164 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA2.57MShares$149 Million0.02% of portfolio
-
Mairs & Power Inc St Paul, MN2.45MShares$142 Million1.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.42MShares$140 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA2.34MShares$136 Million0.35% of portfolio
-
Victory Capital Management Inc1.42MShares$82.4 Million0.06% of portfolio
-
Geode Capital Management, LLC Boston, MA1.29MShares$74.8 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.27MShares$73.9 Million0.05% of portfolio
Latest Institutional Activity in FUL
Top Purchases
Top Sells
About FUL
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives such as, thermoplastic, thermoset, reactive, and water-based and solvent-based products for applications in various markets, including food and beverage containers, flexible packaging, consumer goods, package integrity and re-enforcement, and non-durable goods; corrugation, folding carton, tape and label, paper converting, envelopes, books, multi-wall bags, sacks, and tissue and towel; disposable diapers, feminine care, and medical garments; and health and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives such as reactive, light cure, two-part liquids, silicone, polyurethane, film, and fast cure products to the appliances and filters, windows, doors and wood flooring, and textile, transportation, electronics, medical, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for tile setting, commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly through distributors and retailers. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.
Insider Transactions at FUL
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 08
2025
|
Joao Magalhaes Sr. VP, Engineering Adhesives |
SELL
Open market or private sale
|
Direct |
1,099
-25.07%
|
$61,544
$56.31 P/Share
|
Aug 08
2025
|
Joao Magalhaes Sr. VP, Engineering Adhesives |
BUY
Exercise of conversion of derivative security
|
Direct |
1,099
+20.04%
|
$36,267
$33.38 P/Share
|
Aug 07
2025
|
Joao Magalhaes Sr. VP, Engineering Adhesives |
SELL
Open market or private sale
|
Direct |
1,046
-24.15%
|
$58,576
$56.2 P/Share
|
Aug 07
2025
|
Joao Magalhaes Sr. VP, Engineering Adhesives |
BUY
Exercise of conversion of derivative security
|
Direct |
1,046
+19.45%
|
$35,564
$34.43 P/Share
|
Aug 05
2025
|
Nathan D. Weaver Exec VP, Business Transform. |
SELL
Discretionary transaction
|
Indirect |
213
-100.0%
|
$11,928
$56.84 P/Share
|
Jul 10
2025
|
Robert J Martsching VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
9,546
-38.92%
|
$610,944
$64.3 P/Share
|
Jul 10
2025
|
Robert J Martsching VP, Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
9,546
+28.02%
|
$315,018
$33.38 P/Share
|
Apr 07
2025
|
Srilata Zaheer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,346
+50.0%
|
$69,992
$52.75 P/Share
|
Apr 07
2025
|
Celeste Beeks Mastin President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,421
-4.11%
|
$73,892
$52.75 P/Share
|
Apr 07
2025
|
Celeste Beeks Mastin President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,311
+6.95%
|
$68,172
$52.75 P/Share
|
Apr 07
2025
|
Celeste Beeks Mastin President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,241
+20.72%
|
$220,532
$52.75 P/Share
|
Apr 01
2025
|
Celeste Beeks Mastin President and CEO |
BUY
Open market or private purchase
|
Indirect |
3,500
+50.0%
|
$196,000
$56.66 P/Share
|
Jan 31
2025
|
Nathan D. Weaver Exec VP, Business Transform. |
SELL
Payment of exercise price or tax liability
|
Direct |
88
-1.25%
|
$5,544
$63.13 P/Share
|
Jan 31
2025
|
Nathan D. Weaver Exec VP, Business Transform. |
BUY
Exercise of conversion of derivative security
|
Direct |
328
+4.44%
|
$20,664
$63.13 P/Share
|
Jan 28
2025
|
Du Xinyu Sr. VP, Global R&D |
SELL
Open market or private sale
|
Direct |
69
-2.97%
|
$4,347
$63.68 P/Share
|
Jan 27
2025
|
Du Xinyu Sr. VP, Global R&D |
SELL
Open market or private sale
|
Direct |
240
-9.36%
|
$15,120
$63.73 P/Share
|
Jan 26
2025
|
Du Xinyu Sr. VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
197
+7.14%
|
$12,214
$62.77 P/Share
|
Jan 26
2025
|
Zhiwei Cai Executive Vice President, EA |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.5%
|
$11,904
$62.77 P/Share
|
Jan 26
2025
|
Zhiwei Cai Executive Vice President, EA |
BUY
Exercise of conversion of derivative security
|
Direct |
680
+1.73%
|
$42,160
$62.77 P/Share
|
Jan 26
2025
|
Heather Campe Sr. VP, International Growth |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-0.61%
|
$8,432
$62.77 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 63.5K shares |
---|---|
Grant, award, or other acquisition | 4.7K shares |
Open market or private purchase | 3.5K shares |
Payment of exercise price or tax liability | 16.5K shares |
---|---|
Discretionary transaction | 213 shares |
Open market or private sale | 12K shares |